Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of MAGED1 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of MAGED1 mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of MAGED1 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MAGED1 mRNA | affects expression | 16483693
|
D003042 |
Cocaine |
Cocaine affects the expression of MAGED1 mRNA | affects expression | 15681117
|
D003520 |
Cyclophosphamide |
MAGED1 protein affects the susceptibility to Cyclophosphamide | affects response to substance | 16217747
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of MAGED1 mRNA | decreases expression | 20106945
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of MAGED1 mRNA | increases expression | 18042831
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAGED1 mRNA | affects cotreatment|increases expression | 17942748
|
D005472 |
Fluorouracil |
MAGED1 protein affects the susceptibility to Fluorouracil | affects response to substance | 16217747 15548681
|
D007657 |
Ketone Bodies |
Ketone Bodies results in increased expression of MAGED1 mRNA | increases expression | 16807920
|
D008727 |
Methotrexate |
MAGED1 protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
D008942 |
Mitoxantrone |
MAGED1 protein affects the susceptibility to Mitoxantrone | affects response to substance | 16217747
|
C041786 |
palm oil |
palm oil results in increased expression of MAGED1 mRNA | increases expression | 18042831
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MAGED1 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of MAGED1 mRNA | increases expression | 18175754
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAGED1 mRNA | affects cotreatment|increases expression | 17942748
|
D019772 |
Topotecan |
MAGED1 protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
8.47 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.47 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.52 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.91 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.08 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.30 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.30 | 17638652 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.78 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.78 | 16835633 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.55 | 17963324 15504547 16511603 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.55 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.81 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
16.85 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
16.85 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
16.85 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.64 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.09 | 17286800 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.42 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.63 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.63 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.76 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.73 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.35 | 16978400 11325840 15136595 18234424 18323546 17388661 15093573 12006526 17020986 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.35 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.35 | 16595493 16110121 16557594 19217205 18608205 18357371 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.35 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.35 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.64 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.06 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.06 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
8.81 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.81 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
8.81 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
8.81 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
8.81 | 16799960 17045692 17971768 16332177 18930000 17088986 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.85 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
6.74 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
6.74 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
2.48 | 17066447 16757204 16280240 18986760 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.34 | 18850075 18670907 16120746 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.55 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.47 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.47 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.12 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
13.15 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
13.15 | 16105132 17681005 16919318 11677210 17333356 15861022 17110522 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
13.15 | 19176532 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.71 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.08 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D019970 |
Cocaine-Related Disorders |
|
Cocaine |
5.68 | 19606084 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.23 | 17287894 15001691 17172411 16510598 17016597 17725105 17169374 17018589 18772588 16340194 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.00 | 18288408 17401013 17255274 18802399 17016601 18509181 14970324 17695437 17094418 16524972 17594712 16282729 15289873 17454858 16331619 18383874 18448328 16303861 18949393 15148649 16391804 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.02 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
2.74 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.74 | 10048152 15322242 20055451 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
10.76 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.76 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.20 | 19747007 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.96 | 18093676 15276878 15643279 12388444 18433785 18372110 12913760 18295254 10498854 18710439 16413132 16989017 16614059 11948286 18483878 17010015 10700343 17979934 16651033 12161096 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.76 | 16733453 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.40 | 18249437 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.08 | 20191521 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.74 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.03 | 11751995 15331540 10990075 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.21 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.66 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
11.87 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
11.87 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
11.87 | 12594235 14725611 16227642 12153990 16177239 19923254 19085960 19370779 15968718 11743745 11834606 17562736 12705907 10774834 17522070 12392966 12958197 11529661 17906064 16393943 19164858 19416960 16109766 18713872 11287661 11461765 10915739 12540782 18071297 16781746 14986274 16485898 16081117 15619225 11421492 11739529 19739265 10663392 14550746 19420014 2444490 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
11.87 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.87 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.07 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.73 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.42 | 18367378 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.40 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.40 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.87 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.15 | 12538720 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.98 | 10568697 9294722 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.18 | 11006010 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
2.44 | 16337965 16785472 15173087 16481741 17638652 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
18.41 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
18.41 | 18296743 19551842 17967931 19004024 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
18.41 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
18.41 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.42 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
14.50 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
14.50 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.50 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.65 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.18 | 8708960 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.85 | 16145905 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.48 | 11389073 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.57 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
12.04 | 15172196 16376943 11014644 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
12.04 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.36 | 15162350 15102660 18337622 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.31 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Mitoxantrone |
4.12 | 16019553 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.51 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.39 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.25 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.29 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.51 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.13 | 16221962 19176532 18467677 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.13 | 15340226 16120746 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
3.75 | 16135485 17606976 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.02 | 8697196 16959395 15340226 18606429 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.66 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.55 | 21332399 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.14 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.57 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.89 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.89 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.77 | 16945680 16569931 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.30 | 16076520 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.42 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
6.78 | 7193160 16517039 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.78 | 17937319 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
4.84 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.84 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
12.17 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
12.17 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
12.17 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.29 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.41 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.71 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.71 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
17.45 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
17.45 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
17.45 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
17.45 | 16985049 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.06 | 9562676 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
3.47 | 10602166 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
6.91 | 18587576 17802794 17658394 17008537 17296974 18172266 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Mitoxantrone |
6.91 | 18172266 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.05 | 10373061 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.93 | 10052129 11830472 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
6.88 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
6.88 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.12 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.12 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.62 | 19784758 11587558 12969438 16611625 19014921 12587719 19460945 16610002 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.20 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
10.54 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
10.54 | 15113037 18383874 16603448 17045692 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
10.54 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.54 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
5.64 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.64 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
4.99 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
2.33 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.33 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.76 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
7.95 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
7.95 | 17352296 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
10.25 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
10.25 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
4.13 | 11911406 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
10.70 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
10.70 | 16388313 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.76 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.60 | 18986760 16757204 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.24 | 17488658 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.47 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Cocaine |
6.03 | 18072171 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
6.03 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.98 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.91 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.23 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.23 | 18551238 7678174 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
11.77 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
11.77 | 18600527 18239605 16928823 |
MESH:D009369 |
Neoplasms |
|
Mitoxantrone |
11.77 | 16640825 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
11.77 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.41 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.24 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.17 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
7.35 | 16115947 15176712 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
7.35 | 15176712 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.83 | 18514411 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.85 | 8761367 12837982 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.41 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.28 | 8291058 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.40 | 19632207 18457598 18674790 16723640 20132043 21332399 20518802 17217161 11836018 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.40 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.75 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.75 | 16049721 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.68 | 16517039 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.73 | 16870215 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
6.73 | 12161096 18093676 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
5.55 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.55 | 15113037 16929163 19003803 16500647 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.65 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.22 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.52 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.18 | 12371664 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.78 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.16 | 11896295 11399792 11222880 11118676 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.72 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.72 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.72 | 18760546 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.28 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
5.86 | 16882103 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
5.86 | 17410198 |
MESH:D011618 |
Psychotic Disorders |
|
Cocaine |
4.79 | 16134406 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.26 | 16636934 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.97 | 15538739 18722050 16160472 18286688 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.67 | 17352296 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.36 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.80 | 18990726 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.78 | 16636934 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
9.82 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
9.82 | 18551238 |
MESH:D012640 |
Seizures |
|
Cocaine |
9.82 | 10454489 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.02 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.91 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.48 | 16517039 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.00 | 19084572 18567086 17498489 17522103 15786421 16424979 16951190 18396642 19015929 17172411 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.02 | 12837982 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
4.99 | 9562676 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.58 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.11 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.87 | 12697716 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.95 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.30 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.30 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
8.30 | 14692829 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
11.87 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
11.87 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.94 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
3.84 | 16803524 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.26 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.96 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.57 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.50 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.22 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.70 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.41 | 17120751 |